Wuhan Fine Biotech (FineTest)

Founded in 2013, Wuhan Fine Biotech Co., Ltd. (FineTest®) develops research reagents for life science applications, with expertise spanning immunology, molecular biology, protein expression and purification, and antibody development. The company manufactures ELISA kits, antibodies, recombinant proteins and related assay reagents that enable researchers to quantify biomarkers, investigate signalling pathways and study cellular and physiological processes. Operating from its facilities in Wuhan, China, FineTest supports research in areas including immunology, metabolism, neuroscience, signal transduction, inflammation and disease biology through validated analytical tools and quality-controlled manufacturing processes.

FineTest’s product portfolio includes thousands of ELISA kits for human, animal and veterinary research, alongside a broad range of monoclonal and polyclonal antibodies, secondary antibodies, recombinant proteins and cell function assay kits. Its offerings support workflows such as protein detection and quantification, western blotting, immunohistochemistry, immunofluorescence, flow cytometry and cell-based assays. The company also provides custom antibody and recombinant protein production services, with protein expression capabilities across bacterial, mammalian, insect and other expression systems. Product families include Accquant® ELISA Kits, veterinary ELISA assays, cytokine detection kits, recombinant proteins and research antibodies for basic, translational and preclinical research.

Europa Biosite's subsidiaries distribute for Wuhan Fine Biotech (FineTest) in Canada, Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, Sweden, Switzerland and the United States of America.